{
"IBRX": "ImmunityBio (IBRX) Soars to New High on Anktiva Future ExpansionImmunityBio’s EU Anktiva Nod Sparks Questions On Valuation And MomentumImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note ChangeStock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder CancerWhy ImmunityBio Stock Is Soaring TodayBC-Most Active Stocks",

"KLAR": "Sweden's Klarna surpasses $1 billion in fourth-quarter revenue as US growth speeds upKlarna (KLAR) Scaling Operations Through Strategic PartnershipsXOVR is A $1.5 Billion ETF That Holds SpaceX Pre-IPO, But The Returns Are AwfulKlarna Lawsuits Put Credit Loss Reserves And AI Workforce Shift Under ScrutinyGoldman Sachs scraps DEI criteria for its board as the business case for boardroom diversity only grows more compelling",

"ONDR": "Ondas (ONDS) Soars 10.15% as Firm Hints At Multi-Billion-Dollar MarketOndas Expands Counter Drone And Demining Reach With New Global DealsCritical Report on Ondas (ONDS) Precedes Defense Unit’s $30M Contract in IsraelBC-Most Active StocksOndas (ONDS) Climbs 8% as Firm Guns for Multi-Billion-Dollar Market"
}